Home › Funds › Corundum Group, Inc. › ABBV

Corundum Group, Inc. position in ABBV

ABBVIE INC · Health Care

Corundum Group, Inc. reported holding 8,240 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.74% of its reported portfolio and ranking #27 among its reported holdings. Corundum Group, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.24K sh
Reported value held$2.16M
Portfolio Weight0.74%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Corundum Group, Inc.'s ABBV position evolved

Corundum Group, Inc. first disclosed a stake in ABBV in Q3 2023 at 4,862 shares (US$725K). The position peaked in Q3 2026 at 8,240 shares, worth US$2.2M. Across 13 filings, Corundum Group, Inc. increased the stake 6 time(s), trimmed it 5 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 8,240 shares valued at US$2.2M — an increase of 240 shares quarter over quarter.. Notable position changes include a 90% increase in Q2 2024 (shares rose 16% over the following quarter), a 83% increase in Q4 2024 (shares rose 19% over the following quarter), a 47% increase in Q2 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.86K $724.73K New
Q4 2023 4.97K $769.89K Add
Q1 2024 4.87K $886.10K Reduce
Q2 2024 9.23K $1.58M Add
Q3 2024 5.02K $991.75K Reduce
Q4 2024 9.18K $1.63M Add
Q1 2025 5.13K $1.07M Reduce
Q2 2025 7.52K $1.40M Add
Q3 2025 7.50K $1.74M Hold
Q4 2025 8.31K $1.90M Add
Q1 2026 8.05K $1.75M Reduce
Q2 2026 8.00K $2.01M Reduce
Q3 2026 8.24K $2.16M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 31 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Corundum Group, Inc. held ABBV?

Corundum Group, Inc. has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Corundum Group, Inc.'s current position in ABBV?

As of Q3 2026, Corundum Group, Inc. holds 8.24K shares of ABBV (ABBVIE INC), valued at $2.16M, representing 0.74% of its reported portfolio and ranking #27.

Has Corundum Group, Inc. been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Corundum Group, Inc. increased its position in ABBV. The position peaked in Q3 2026 at 8.24K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.